Evidence map›Paper›PMID 31723679›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2016

Screening of the antimycobacterial activity of novel lipophilic agents by the modified broth based method.

Mehdi Zandhaghighi, Kiarash Ghazvini, Zahra Meshkat, Seyed Abdolrahim Rezaee, Mohammad Derakhshan, Saman Soleimanpour, Farzin Hadizadeh

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mehdi ZandhaghighiAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Kiarash GhazviniAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra MeshkatAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyed Abdolrahim RezaeeAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad DerakhshanAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Saman SoleimanpourAntimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Farzin HadizadehBiotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the introduced susceptibility methods of

Indexed as

Antitubercular agentsDihydropyridinesMicrobial sensitivity testsPreclinical drug evaluation

Identifiers

PMID31723679
PMCPMC6850257
OpenAlexW2309758201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.